Skip to main content
Clinical Trials/JPRN-UMIN000026844
JPRN-UMIN000026844Recruiting未知

lcerative colitis- real world study for the effects of biologics, anti-TNF alpha- golimumab in remission- induction and maintenance- (UC- BINGO) study - UC- BINGO study

Saitama Medical University, Saitama Medical Center0 sites40 target enrollmentStarted: June 1, 2017Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Recruiting
Sponsor
Enrollment
40

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
15years-old to 70years-old (—)
Sex
All

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Patients who has contraindication of golimumab Patients in pregnancy and lactation period Patients who has and had malignancy Patients who don nott have informed conents Patients determined not to be suitable for this study by physicians

Investigators

Sponsor
Saitama Medical University, Saitama Medical Center

Similar Trials